INDIANAPOLIS, Jan. 21, 2016 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Eli Lilly and Company's (NYSE: LLY) Humulin ® R U-500 KwikPen ® (insulin human injection) 500 units ...
BD announced the launch of the BD U-500 Insulin Syringe, the first insulin syringe designed for patients with diabetes taking Humulin R U-500 insulin (regular insulin [human, rDNA origin]; Eli Lilly).
The U.S. Food and Drug Administration (FDA) has approved Eli Lilly and Company's (NYSE: LLY) Humulin ® R U-500 KwikPen ® (insulin human injection) 500 units/mL, a pre-filled device containing Humulin ...
Eli Lilly announced the launch of Humulin R U-500 KwikPen (insulin human injection), a prefilled device containing a highly concentrated formulation of insulin. Eli Lilly announced the launch of ...
Insulet To Develop New Version Of The OmniPod Insulin Pump For Use With Humulin R U-500 Concentrated Insulin For People With Type 2 Diabetes Bedford, MA (Marketwired) - Insulet Corporation (NASDAQ: ...
The US Food and Drug Administration approved a dedicated syringe for the administration of Humulin R U-500 insulin, which is now the only device approved for use with U-500 insulin vial. Humulin R ...
The US Food and Drug Administration has approved a dedicated syringe (Becton Dickinson) for administering Humulin R U-500 insulin (Lilly). Humulin R U-500 is indicated for blood glucose control in ...
The US Food and Drug Administration (FDA) has approved the first prefilled pen device containing concentrated U-500 strength insulin (Humulin R U-500 KwikPen [insulin human injection] 500 units/mL, ...
The BD U-500 Insulin Syringe is specifically designed to administer the Humulin R U-500 insulin among patients properly. The Humulin R U-500 insulin is prescribed to patients who need a higher dose of ...
The active ingredient in Humulin N is isophane insulin human, which is a biologic. Humulin N belongs to a group of drugs called intermediate-acting insulins. Humulin N comes as a suspension (a type of ...
BEDFORD, MA--(Marketwired - May 2, 2013) - Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today announced it has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results